{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:36:11Z","timestamp":1772825771546,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T00:00:00Z","timestamp":1363219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s13277-013-0647-9","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T03:56:35Z","timestamp":1363146995000},"page":"1441-1450","source":"Crossref","is-referenced-by-count":11,"title":["High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma"],"prefix":"10.1007","volume":"34","author":[{"given":"Yajun","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingxin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baocun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,14]]},"reference":[{"key":"647_CR1","volume-title":"WHO classification of tumors of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: The International Agency for Research on Cancer; 2008.","edition":"4"},{"issue":"1","key":"647_CR2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-4608(02)00801-4","volume":"142","author":"R Okhowat","year":"2003","unstructured":"Okhowat R, Dorner S, Hinterberger W, Fonatsch C. Unusual karyotype aberrations involving 2p12, 3q27, 18q21, 8q24, and 14q32 in a patient with non-Hodgkin lymphoma\/acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2003;142(1):60\u20134.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"647_CR3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","volume":"19","author":"A Kanungo","year":"2006","unstructured":"Kanungo A, Medeiros LJ, Abruzzo LV, Lin P. Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis. Mod Pathol. 2006;19(1):25\u201333.","journal-title":"Mod Pathol"},{"issue":"11","key":"647_CR4","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3109\/10428194.2011.589548","volume":"52","author":"S Subramaniyam","year":"2011","unstructured":"Subramaniyam S, Fraser CR, Rao PH, Feldman E, Ely S, Mathew S. De novo B lymphoblastic leukemia\/lymphoma in an adult with t(14;18)(q32;q21) and c-MYC gene rearrangement involving 10p13. Leuk Lymphoma. 2011;52(11):2195\u20139.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"647_CR5","first-page":"170","volume":"14","author":"Z Amirghofran","year":"2011","unstructured":"Amirghofran Z, Daneshbod Y, Esmaeilbeig M. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia. Arch Iran Med. 2011;14(3):170\u20134.","journal-title":"Arch Iran Med"},{"issue":"3","key":"647_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/gcc.10178","volume":"36","author":"S Janz","year":"2003","unstructured":"Janz S, Potter M, Rabkin CS. Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer. 2003;36(3):211\u201323.","journal-title":"Genes Chromosomes Cancer"},{"key":"647_CR7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood.V83.7.1757.1757","volume":"83","author":"F Lo Coco","year":"1994","unstructured":"Lo Coco F, Ye BH, Lista F, Corradini P, Offit K, Knowles DM, et al. Rearrangements of the BCL6 gene in diffuse large cell nonHodgkin\u2019s lymphoma. Blood. 1994;83:1757\u20139.","journal-title":"Blood"},{"key":"647_CR8","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","volume":"83","author":"C Bastard","year":"1994","unstructured":"Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin\u2019s lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 1994;83:2423\u20137.","journal-title":"Blood"},{"issue":"10","key":"647_CR9","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood.V85.10.2877.bloodjournal85102877","volume":"85","author":"C Bastard","year":"1995","unstructured":"Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin\u2019s lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood. 1995;85(10):2877\u201384.","journal-title":"Blood"},{"key":"647_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V84.2.397.397","volume":"84","author":"G Gaidano","year":"1994","unstructured":"Gaidano G, Lo Coco F, Ye BH, Shibata D, Levine AM, Knowles DM, et al. Rearrangements of the BCL-6 gene in acquired immunodeficiency syndrome-associated non-Hodgkin\u2019s lymphoma: association with diffuse large-cell subtype. Blood. 1994;84:397\u2013402.","journal-title":"Blood"},{"issue":"2","key":"647_CR11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1056\/NEJM199407143310202","volume":"331","author":"K Offit","year":"1994","unstructured":"Offit K, Lo Coco F, Louie DC, Parsa NZ, Leung D, Portlock C, et al. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. N Engl J Med. 1994;331(2):74\u201380.","journal-title":"N Engl J Med"},{"issue":"6306","key":"647_CR12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","volume":"349","author":"TJ McDonnell","year":"1991","unstructured":"McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature. 1991;349(6306):254\u20136.","journal-title":"Nature"},{"issue":"8","key":"647_CR13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.exphem.2011.05.002","volume":"39","author":"N Sasaki","year":"2011","unstructured":"Sasaki N, Kuroda J, Nagoshi H, Yamamoto M, Kobayashi S, Tsutsumi Y, et al. Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression. Exp Hematol. 2011;39(8):817\u201328.","journal-title":"Exp Hematol"},{"issue":"11","key":"647_CR14","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin\u2019s Disease Staging Classification. Cancer Res. 1971;31(11):1860\u20131.","journal-title":"Cancer Res"},{"issue":"2","key":"647_CR15","first-page":"416","volume":"95","author":"A Reiter","year":"2000","unstructured":"Reiter A, Schrappe M, Ludwig WD, Tiemann M, Parwaresch R, Zimmermann M, et al. Intensive ALL-type therapy without local radiotherapy provides a 90\u00a0% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM Group report. Blood. 2000;95(2):416\u201321.","journal-title":"Blood"},{"issue":"4","key":"647_CR16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1182\/blood.V57.4.679.679","volume":"57","author":"CN Coleman","year":"1981","unstructured":"Coleman CN, Cohen JR, Burke JS, Rosenberg SA. Lymphoblastic lymphoma in adults: results of a pilot protocol. Blood. 1981;57(4):679\u201384.","journal-title":"Blood"},{"issue":"6","key":"647_CR17","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","volume":"104","author":"DA Thomas","year":"2004","unstructured":"Thomas DA, O'Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104(6):1624\u201330.","journal-title":"Blood"},{"issue":"7","key":"647_CR18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4(7):844\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"647_CR19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"CP Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275\u201382.","journal-title":"Blood"},{"issue":"1","key":"647_CR20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2006.05969.x","volume":"133","author":"Y Zhou","year":"2006","unstructured":"Zhou Y, Ye H, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R, et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol. 2006;133(1):35\u201342.","journal-title":"Br J Haematol"},{"issue":"4","key":"647_CR21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pbc.21666","volume":"51","author":"KJ Smock","year":"2008","unstructured":"Smock KJ, Nelson M, Tripp SR, Sanger WG, Abromowitch M, Cairo MS, et al. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group. Pediatr Blood Cancer. 2008;51(4):489\u201394.","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"647_CR22","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V99.12.4265","volume":"99","author":"JJ Biagi","year":"2002","unstructured":"Biagi JJ, Seymour JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood. 2002;99(12):4265\u201375.","journal-title":"Blood"},{"issue":"25","key":"647_CR23","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","volume":"24","author":"GW Imhoff Van","year":"2006","unstructured":"Van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, et al. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(25):4135\u201342.","journal-title":"J Clin Oncol"},{"issue":"5","key":"647_CR24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood.V62.5.1142.1142","volume":"62","author":"GJ Mufti","year":"1983","unstructured":"Mufti GJ, Hamblin TJ, Oscier DG, Johnson S. Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. Blood. 1983;62(5):1142\u20136.","journal-title":"Blood"},{"issue":"1","key":"647_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V97.1.270","volume":"7","author":"E Hyjek","year":"2001","unstructured":"Hyjek E, Chadburn A, Liu YF, Cesarman E, Knowles DM, et al. BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus. Blood. 2001;7(1):270\u20136.","journal-title":"Blood"},{"key":"647_CR26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1006\/excr.1995.1083","volume":"217","author":"MC Marin","year":"1995","unstructured":"Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo. Exp Cell Res. 1995;217:240\u20137.","journal-title":"Exp Cell Res"},{"issue":"4","key":"647_CR27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2559.2011.03978.x","volume":"59","author":"G Tapia","year":"2011","unstructured":"Tapia G, Lopez R, Mu\u00f1oz-M\u00e1rmol AM, Mate JL, Sanz C, Marginet R, et al. Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas. Histopathology. 2011;59(4):672\u20138.","journal-title":"Histopathology"},{"issue":"11","key":"647_CR28","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2402657","volume":"16","author":"F Jardin","year":"2002","unstructured":"Jardin F, Buchonnet G, Parmentier F, Contentin N, Lepr\u00eatre S, Lenain P, et al. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements. Leukemia. 2002;16(11):2318\u201325.","journal-title":"Leukemia"},{"issue":"1","key":"647_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt B, Zimmermann M, Oschlies I, Niggli F, Mann G, Parwaresch R, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39\u201349.","journal-title":"Br J Haematol"},{"issue":"4","key":"647_CR30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","volume":"152","author":"S Ducassou","year":"2011","unstructured":"Ducassou S, Ferlay C, Bergeron C, Girard S, Laureys G, Pacquement H, et al. Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. Br J Haematol. 2011;152(4):441\u201351.","journal-title":"Br J Haematol"},{"issue":"12","key":"647_CR31","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood-2002-01-0110","volume":"99","author":"D Hoelzer","year":"2002","unstructured":"Hoelzer D, G\u00f6kbuget N, Digel W, Faak T, Kneba M, Reutzel R, et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood. 2002;99(12):4379\u201385.","journal-title":"Blood"},{"issue":"11","key":"647_CR32","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","volume":"4","author":"CN Coleman","year":"1986","unstructured":"Coleman CN, Picozzi Jr VJ, Cox RS, McWhirter K, Weiss LM, Cohen JR, et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol. 1986;4(11):1628\u201337.","journal-title":"J Clin Oncol"},{"issue":"1\u20132","key":"647_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428199909145953","volume":"36","author":"U Kaiser","year":"1999","unstructured":"Kaiser U, Uebelacker I, Havemann K. Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients. Leuk Lymphoma. 1999;36(1\u20132):101\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"647_CR34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","volume":"10","author":"P Morel","year":"1992","unstructured":"Morel P, Lepage E, Brice P, Dupriez B, D'Agay MF, Fenaux P, et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol. 1992;10(7):1078\u201385.","journal-title":"J Clin Oncol"},{"issue":"5","key":"647_CR35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pbc.21941","volume":"52","author":"T Mitsui","year":"2009","unstructured":"Mitsui T, Mori T, Fujita N, Inada H, Horibe K, Tsurusawa M, et al. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan. Pediatr Blood Cancer. 2009;52(5):591\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"21","key":"647_CR36","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1200\/JCO.2008.21.1318","volume":"27","author":"E Coustan-Smith","year":"2009","unstructured":"Coustan-Smith E, Sandlund JT, Perkins SL, Chen H, Chang M, Abromowitch M, et al. Minimal disseminated disease in childhood T-cell lymphoblastic lymphoma: a report from the children\u2019s oncology group. J Clin Oncol. 2009;27(21):3533\u20139.","journal-title":"J Clin Oncol"},{"issue":"20","key":"647_CR37","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.2008.19.3367","volume":"27","author":"B Burkhardt","year":"2009","unstructured":"Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, et al. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the Berlin\u2013Frankfurt\u2013Muenster Group. J Clin Oncol. 2009;27(20):3363\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0647-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-0647-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-0647-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T20:31:39Z","timestamp":1595536299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-0647-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,14]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-0647-9","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,14]]}}}